Dysregulation of AP-1 and NF-κB activation is implicated in chronic inflammatory conditions and cancer, as chronic activation promotes cell proliferation and survival while inhibiting apoptosis, thus facilitating tumorigenesis. Here, NFKB1 is linked to cancer.